| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
Ethyl (2-oxopyrrolidin-1-yl)acetate
|
67118-31-4 |
alpha-乙基-2-氧代-1-吡咯烷乙酸
|
alpha-乙基-2-氧代-1-吡咯烷乙酸;左乙拉西坦中间体(LVA20);左乙拉西坦杂质EP杂质A;乙基-2-氧代-1-吡咯烷乙酸;2-(2-氧代-1-吡咯烷基)丁酸;乙拉西坦羧酸
|
C8H13NO3 |
171.19 | 1308068-626-2 |
|
3-Cyanobenzyl bromide
|
28188-41-2 |
3-氰基苄基溴
|
间氰基苄基溴;间氰基溴苄;3-氰基苄基溴;间氰基溴甲苯;α-溴间甲基苯甲腈;ALPHA-溴间苄基腈;3-氰基苄基溴3-溴甲基苯甲腈;Α-溴间甲基苯甲腈
|
C8H6NBr |
196.04394 | 248-890-1 |
|
Lercanidipine Impurity 2
|
75130-24-4 |
乐卡地平杂质
|
|
C19H19N3O6 |
385.37066 | 616-188-8 |
|
Lenvatinib Impurity 6
|
417717-21-6 |
乐伐替尼杂质F
|
乐伐替尼杂质F;乐伐替尼羧酸杂质;乐伐替尼杂质O;仑伐替尼杂质1;4-[3-氯-4-[[(环丙基氨基)羰基]氨基]苯氧基]-7-甲氧基-6-喹啉羧酸;仑伐替尼杂质F
|
C21H18ClN3O5 |
427.83772 | |
|
Lenvatinib Impurity 5
|
417717-20-5 |
乐伐替尼杂质E
|
乐伐替尼杂质E;4-[3-氯-4-[[(环丙基氨基)羰基]氨基]苯氧基]-7-甲氧基-6-喹啉羧酸甲酯;仑伐替尼杂质E
|
C22H20ClN3O5 |
441.8643 | |
|
Lenvatinib Impurity 4
|
417717-04-5 |
乐伐替尼杂质D
|
乐伐替尼杂质D;仑伐替尼杂质D;O-去甲基乐伐替尼杂质
|
C20H17ClN4O4 |
412.8313 | |
|
trans (15S)-Latanoprost
|
1235141-39-5 |
15S-5,6-反式-拉坦前列素
|
TRANS (15S)拉坦前列素;反式(15S)拉坦前列素;15S-5,6-反式-LATANOPROST
|
C26H40O5 |
432.5928 | |
|
Larotrectinib Impurity 4(Larotrectinib DFP-PPP Impurity)
|
1223404-89-4 |
NA
|
LOXO101中间体5
|
C16H14F2N4 |
300.305966 | |
|
1-(1H-Benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid
|
1163685-30-0 |
雷贝拉唑USP RC A
|
雷贝拉唑USP RC A;雷贝拉唑杂质 13;雷贝拉唑EP杂质C;雷贝拉唑相关化合物A
|
C14H11N3O3 |
269.25544 | |
|
Lansoprazole related substance B
|
131926-99-3 |
兰索拉唑磺酸盐
|
兰索拉唑磺酸盐;兰索拉唑砜;LANSOPRAZOLE-2;兰素拉唑相关物质A;兰索拉唑EP杂质B;2-[-[(3-甲基-4-(2,2,2-三氟乙氧基)-2-吡啶基)甲基]磺酰基]苯并咪唑;右旋兰索拉唑杂质B;兰索拉唑磺化物
|
C16H14F3N3O3S |
385.36 | |
|
Lansoprazole Impurity 31
|
1187926-84-6 |
2-[ [(3-甲基-4-(2,2,2-三氟乙氧基)-2-吡啶基)甲基]亚硫酰基]-1-(2,2,2-三氟乙基)-苯并咪唑
|
Dexlansoprazole Impurity;Dexlansoprazole IMP;1H-BenziMidazole, 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]Methyl]sulfinyl]-1-(2,2,2-trifluoroethyl)-;Dexlansoprazole iMpurity D;2-(((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)sulfinyl)-1-(2,2,2-trifluoroethyl)-1H-benzo[d]imidazole;Lansoprazole Impurity O;Lansoprazole-9;Lansoprazole Impurity 31
|
C18H15F6N3O2S |
451.3860192 | |
|
Desmethyl Lacosamide
|
175481-38-6 |
去甲拉考沙胺
|
LACOSAMIDE O-去甲基杂质;LACOSAMIDE杂质F;去甲拉考沙胺;去甲拉科酰胺;去甲基拉科酰胺
|
C12H16N2O3 |
236.26704 | |
|
2,2'-BIPYRROL
|
10087-64-6 |
2,2'-二吡咯
|
2,2'-二吡咯
|
C8H8N2 |
132.16 | |
|
(3-Benzoylphenyl)-Acetonitrile
|
21288-34-6 |
3-苯甲酰苯基乙腈
|
3-苯甲酰苯基乙腈;3-苯甲酰基乙腈;酮基布洛芬EP杂质I;酮洛芬EP杂质I
|
C15H11NO |
221.25394 | 244-315-3 |
|
Dexketoprofen-Related Compound A
|
107257-20-5 |
酮洛芬相关物质A
|
酪洛芬杂质 D;酮洛芬相关物质A;酮洛芬杂质D;酮基布洛芬杂质D;酮洛芬有关物质 A;ALPHA-甲基-3-(4-甲基苯甲酰基)苯乙酸;酮基布洛芬EP杂质D;酮洛芬EP杂质D
|
C17H16O3 |
268.30714 | |
|
cis-[2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl-4-methylbenzenesulphonate
|
134071-44-6 |
顺式-[2-(2,4-二氯苯基)-2-(1H-咪唑-1-基甲基)-1,3-二氧戊环-4-基]甲醇对甲苯磺酸酯
|
活性酯 (酮康唑中间体);酮康唑杂质E;顺式-[2-(2,4-二氯苯基)-2-(1H-咪唑-1-基甲基)-1,3-二氧戊环-4-基]甲醇对甲苯磺酸酯;活性酯 (酮康唑);酮康唑EP杂质E;酮康唑中间体
|
C21H20Cl2N2O5S |
483.37 | 603-791-6 |
|
3-(3-chloropropyl)-7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one
|
85175-59-3 |
盐酸伊伐布雷定侧链
|
伊伐布雷定杂质64;7,8-二甲氧基-3-(3-氯代丙基)-1,3-二氢-2H-3-苯并氮杂卓-2-酮 伊伐布雷定中间体 1KG;伊伐布雷定相关化合物4;IVABRADIN-1;伊伐布雷定侧链;伊法布雷定中间体;3-(3-氯丙基)-1;3-二氢-7
|
C15H18ClNO3 |
295.76 | 617-684-7 |
|
Ivabradine Impurity 53
|
73954-34-4 |
伊伐布雷定杂质Q
|
伊伐布雷定相关化合物2;IVABRADIN-7;伊伐布雷定杂质Q;伊伐布雷定杂质19;伊伐布雷定杂质53;伊伐布雷定杂质62
|
C14H21NO5 |
283.32024 | 500-002-8 |
|
Ivabradine Impurity 61
|
85175-65-1 |
3-(3-氯丙基)-7,8-二甲氧基-1,3,4,5-四氢-2H-3-苯并氮杂卓-2-酮
|
伊伐布雷定相关化合物8;IVABRADIN-5;伊伐布雷定杂质61;3-(3-氯丙基)-7,8-二甲氧基-1,3,4,5-四氢-2H-3-苯并氮杂卓-2-酮;伊伐布雷定杂质J;伊伐布雷定杂质M;3-(3-氯丙基)-7,8-甲氧基-1,5-四氢-2H-3-苯并氮杂卓-2-酮;伊伐布雷定杂质8
|
C15H20ClNO3 |
297.777 | 825-254-7 |
|
3,4-DIMETHOXYBENZOYL Chloride
|
3535-37-3 |
3,4-二甲氧基苯甲酰氯
|
伊托必利杂质10;3,4-二甲氧基苯甲酰氯;3,4-二甲氧基苯并基 氯;3,4-二甲氧基苯甲酰氯,98%;3,4-二甲基苯甲酰氯;藜芦酰氯;3,4-二甲氧基苯甲酰氯 25G
|
C9H9CLO3 |
200.6213 | 222-568-0 |
药智官方微信
药智官方微博
